INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 22 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,165,000 | -25.4% | 729,193 | +25.9% | 0.08% | -20.6% |
| Q1 2019 | $4,245,000 | -2.8% | 579,193 | 0.0% | 0.10% | +3.0% |
| Q4 2018 | $4,367,000 | +31.0% | 579,193 | -1.8% | 0.10% | +43.5% |
| Q3 2018 | $3,333,000 | +45.1% | 589,996 | +13.0% | 0.07% | +25.5% |
| Q2 2018 | $2,297,000 | -30.4% | 522,067 | 0.0% | 0.06% | -29.5% |
| Q1 2018 | $3,302,000 | +22.8% | 522,067 | 0.0% | 0.08% | +16.4% |
| Q4 2017 | $2,689,000 | -42.5% | 522,067 | 0.0% | 0.07% | -39.6% |
| Q3 2017 | $4,673,000 | +57.0% | 522,067 | -0.0% | 0.11% | +63.2% |
| Q2 2017 | $2,977,000 | +17.1% | 522,200 | +5.0% | 0.07% | +11.5% |
| Q1 2017 | $2,542,000 | -12.7% | 497,200 | +0.4% | 0.06% | -26.5% |
| Q3 2016 | $2,911,000 | +27.8% | 495,000 | 0.0% | 0.08% | +31.7% |
| Q2 2016 | $2,277,000 | – | 495,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,125,153 | $4,951,000 | 3.63% |
| ACUTA CAPITAL PARTNERS, LLC | 2,962,568 | $13,035,000 | 2.32% |
| DAFNA Capital Management LLC | 568,600 | $2,502,000 | 1.17% |
| MEITAV INVESTMENT HOUSE LTD | 2,450,592 | $11,425,000 | 0.51% |
| SECTORAL ASSET MANAGEMENT INC | 890,386 | $3,918,000 | 0.44% |
| Avoro Capital Advisors LLC | 2,570,705 | $11,311,000 | 0.44% |
| Cormorant Asset Management, LP | 773,816 | $3,405,000 | 0.25% |
| CAXTON CORP | 64,817 | $285,000 | 0.10% |
| Migdal Insurance & Financial Holdings Ltd. | 522,067 | $2,297,000 | 0.06% |
| 683 Capital Management, LLC | 150,000 | $660,000 | 0.04% |